ceo

Business

July 22, 2022June 2, 2024 A Big Week for Psychedelic Stocks: 2 CEOs Step Down, MDMA Patents and a Phase 3 Trial
Compass Pathways and Small Pharma announce executive shakeup, Mydecine and Awakn push forward with new...

Read more

By James Hallifax
Business

July 19, 2022June 2, 2024 Compass Pathways Appoints a New CEO
George Goldsmith will be replaced as Compass Pathways CEO. Is this good or bad news?

Read more

By James Hallifax